ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 100 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2016. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,766,000 | -28.8% | 43,977 | -18.4% | 0.00% | -50.0% |
| Q4 2018 | $2,480,000 | -50.4% | 53,920 | -52.2% | 0.00% | 0.0% |
| Q3 2018 | $5,000,000 | +153.9% | 112,694 | +124.3% | 0.00% | +100.0% |
| Q2 2018 | $1,969,000 | -30.7% | 50,241 | +27.8% | 0.00% | -50.0% |
| Q1 2018 | $2,843,000 | +14.3% | 39,300 | +4.0% | 0.00% | 0.0% |
| Q4 2017 | $2,488,000 | +17.5% | 37,792 | -10.6% | 0.00% | +100.0% |
| Q3 2017 | $2,118,000 | +17.1% | 42,254 | +8.1% | 0.00% | 0.0% |
| Q2 2017 | $1,808,000 | +35.0% | 39,074 | +3.0% | 0.00% | 0.0% |
| Q1 2017 | $1,339,000 | +174.9% | 37,926 | -2.5% | 0.00% | – |
| Q4 2016 | $487,000 | -22.3% | 38,910 | -14.1% | 0.00% | – |
| Q3 2016 | $627,000 | +40.0% | 45,305 | 0.0% | 0.00% | – |
| Q2 2016 | $448,000 | -38.3% | 45,305 | +5.5% | 0.00% | -100.0% |
| Q1 2016 | $726,000 | -40.7% | 42,935 | -22.0% | 0.00% | 0.0% |
| Q4 2015 | $1,225,000 | -6.6% | 55,021 | -1.0% | 0.00% | 0.0% |
| Q3 2015 | $1,312,000 | -62.9% | 55,596 | +28.7% | 0.00% | -66.7% |
| Q2 2015 | $3,532,000 | +62.0% | 43,205 | +83.5% | 0.00% | +50.0% |
| Q1 2015 | $2,180,000 | +174.9% | 23,543 | +20.1% | 0.00% | +100.0% |
| Q4 2014 | $793,000 | +64.5% | 19,609 | -0.4% | 0.00% | – |
| Q3 2014 | $482,000 | +54.5% | 19,695 | 0.0% | 0.00% | – |
| Q2 2014 | $312,000 | +25.3% | 19,695 | +19.7% | 0.00% | – |
| Q1 2014 | $249,000 | +85.8% | 16,458 | +68.7% | 0.00% | – |
| Q4 2013 | $134,000 | -27.2% | 9,758 | 0.0% | 0.00% | – |
| Q3 2013 | $184,000 | – | 9,758 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Boxer Capital, LLC | 1,275,000 | $45,020,000 | 9.84% |
| Aviva Holdings Ltd. | 340,100 | $12,009,000 | 5.60% |
| Aisling Capital LLC | 837,125 | $29,559,000 | 5.38% |
| RA Capital Management | 704,701 | $24,883,000 | 3.05% |
| Rhenman & Partners Asset Management AB | 543,347 | $19,186,000 | 3.04% |
| BB BIOTECH AG | 1,408,542 | $49,736,000 | 1.63% |
| Antipodean Advisors LLC | 91,000 | $3,213,000 | 1.57% |
| Iguana Healthcare Management, LLC | 75,000 | $2,648,000 | 1.31% |
| Crawford Lake Capital Management, LLC | 93,551 | $3,303,000 | 1.31% |
| FT Options LLC | 22,834 | $806,000 | 1.06% |